Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PDE4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC7A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MANEAL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OS9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC01234 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ATP5L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYLK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADCY7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DST - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLAGL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUSP16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
B3GAT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCARB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC39A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNLS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPRM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MEF2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on